Trial Profile

Efficacy and safety of paliperidone palmitate in patients with schizophrenia upon admission to acute units

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 02 Dec 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Paliperidone (Primary)
Indications Schizophrenia
Focus Adverse reactions; Therapeutic Use
Acronyms SHADOW

Most Recent Events

20 Sep 2016 Results of post-hoc analysis presented at the 29th Annual Congress of the European College of Neuropsychopharmacology
12 Jan 2015 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com